Bluestein R H & CO LLC Charles River Laboratories International, Inc. Transaction History

Bluestein R H & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$204.13 - $302.4 $183,512 - $271,857	-899 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $8,198 - $10,082	-22 Reduced 2.39%	899 $371,000
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $6,471 - $8,176	22 Added 2.45%	921 $341,000
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $199,578 - $227,105	899 New	899 $225,000

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.33B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Bluestein R H & CO LLC with notifications on news.